OncLiveIbrutinib Combo Achieves 100% Response Rate in Patients With NHLOncLiveAdding ibrutinib to standard rituximab (R)-CHOP chemotherapy for non-Hodgkin lymphoma (NHL) resulted in an objective response rate of 100%, according to the results of a smal…
Kin donate girl's body, save 4 lives – Times of India
|
Kin donate girl’s body, save 4 lives
Times of India NEW DELHI: The efforts by government and social sector to create awareness about organ donation is finally paying off as more and more people are coming forward for the ‘final act of kindness’. In the last 24 hours, the All India Institute of Medical … |
"PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to … – SBWire (press release)
|
“PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to …
SBWire (press release) Boston, MA — (SBWIRE) — 08/15/2013 — GlobalData has released its new Country report, “PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to 2022″. The chronic heart failure (CHF) market is a mature market that has been slowly … |
Liver allografts donated after cardiac death reduced survival in transplant … – Healio
Liver allografts donated after cardiac death reduced survival in transplant …HealioSubgroup analysis of patients with HCC who received DCD allografts indicated a trend toward improved survival among patients with donor warm ischemia time (WIT) of 15 …
Chronic Heart Failure – Current and Future Players – PR Newswire (press release)
|
Chronic Heart Failure – Current and Future Players
PR Newswire (press release) Summary GlobalData has released its pharma report, “Chronic Heart Failure – Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Chronic heart failure (CHF … PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to …DigitalJournal.com |
Heart's Own Stem Cells Offer Hope for New Treatment of Heart Failure – Science Daily (press release)
New York Daily News |
Heart’s Own Stem Cells Offer Hope for New Treatment of Heart Failure
Science Daily (press release) Aug. 15, 2013 — Researchers at King’s College London have for the first time highlighted the natural regenerative capacity of a group of stem cells that reside in the heart. This new study shows that these cells are responsible for repairing and … Scientists grow human heart tissue using stem cellsNew York Daily News Scientists Rebuild Working Mouse HeartVoice of America Scientists Regenerate Mouse Heart with Human Precursor CellsScience World Report Investor’s Business Daily –Nature World News –Medgadget.com all 26 news articles » |
PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to … – DigitalJournal.com
PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to …DigitalJournal.comThe chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected to lose …
What went wrong with India's TB control – The Hindu
The Hindu |
What went wrong with India’s TB control
The Hindu In India, about 15 per cent are infected by 15 years of age; 40-60 per cent by 40 years. Among them, a few develop lung TB due to various “risk factors.” They cough/spit out billions of TB bacilli. One way to control TB is by treating everyone with … |
PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to … – PR Newswire (press release)
PharmaPoint: Chronic Heart Failure – US Drug Forecast and Market Analysis to …PR Newswire (press release)The chronic heart failure (CHF) market is a mature market that has been slowly overtaken by generic drugs, and more branded products are expected…
Sourasky announces world's first kidney donation, transplant between live HIV … – Jerusalem Post
|
Sourasky announces world’s first kidney donation, transplant between live HIV …
Jerusalem Post “The fact that this was the first live-kidney transplantation between HIV carriers gives a new perspective for medicine with HIV carriers, said Dr. Yvgeny Katzman, an infectious disease expert at Sourasky’s AIDS center. The doctors said that due to … |